Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.595NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.240ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.240ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.240ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.240NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DL.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DL.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
BA.5.1.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.1.529 (Omicron)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.529 (Omicron)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.529 (Omicron)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.529 (Omicron)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.41.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.41.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.41.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.41.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
BF.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
BA.2.3.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AY.33 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.33 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.33 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.33 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
BA.1.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.14.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.14.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.14.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.14.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.14.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.14.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.14.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.14.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1 (Omicron)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used